Dexcom (DXCM) EBT Growth (1y) (2011 - 2026)
Powered by 
Analysis
Dexcom (DXCM) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -29.12% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 26.74% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 35.87% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 53.94% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 12.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.89% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -123.12% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 31.69% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 17.94% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 13.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.69% |
| Mar 31, 2026 | 74.66% |
| Dec 31, 2025 | 61.24% |
| Sep 30, 2025 | 98.59% |
| Jun 30, 2025 | 28.38% |
| Mar 31, 2025 | 16.45% |
| Dec 31, 2024 | -14.18% |
| Sep 30, 2024 | -26.21% |
| Jun 30, 2024 | 17.89% |
| Mar 31, 2024 | 105.43% |
| Dec 31, 2023 | 84.83% |
| Sep 30, 2023 | 64.43% |
| Jun 30, 2023 | 111.55% |
| Mar 31, 2023 | 78.67% |
| Dec 31, 2022 | 1,981.25% |
| Sep 30, 2022 | 30.54% |
| Jun 30, 2022 | -22.45% |
| Mar 31, 2022 | -12.59% |
| Dec 31, 2021 | -95.85% |
| Sep 30, 2021 | 49.13% |